XML 54 R38.htm IDEA: XBRL DOCUMENT v3.25.0.1

REVENUE (Tables)

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of disaggregation by revenue source

The following table presents the Company’s revenues disaggregated by revenue source:

						Year Ended December 31,
(In thousands)						2024						2023						2022
Screening
Medicare Parts B & C						$	776,155					$	701,400					$	545,458
Commercial						1,118,338						992,244						743,238
Other						209,375						171,057						136,007
Total Screening						2,103,868						1,864,701						1,424,703
Precision Oncology
Medicare Parts B & C						$	187,948					$	188,689					$	197,327
Commercial						190,595						181,318						177,518
International						189,092						153,277						117,738
Other						87,364						105,826						108,905
Total Precision Oncology						654,999						629,110						601,488
COVID-19 Testing						$	—					$	5,955					$	58,088
Total						$	2,758,867					$	2,499,766					$	2,084,279

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration